AMGN
Amgen Inc. · $385.16 (-0.6%) · mkt cap $207.9B · P/E 26.8

16 hub catalysts across 5 sources · backtest → · ← Ticker Explorer

Earnings (SEC EDGAR)U.S. House — Congressional TradesFDA Approvals & RecallsSEC EDGAR FilingsU.S. Senate — Congressional Trades

Signal summary

Signals diverge

Bullish and bearish forces are in conflict here — weigh both columns.

100▼ Bear-leanconviction from hub signals
Bullish factors
  • Congress bought (2)
Bearish factors
  • Congress sold (2)
  • FDA recall
  • 2 analyst downgrades
  • Insiders net selling (12 vs 0)

Signal mix for AMGN

Which data feeds have fired on this name — hover a slice for counts.

Best strategy

2-yr backtest · by Sharpe

Connors RSI(2) has fit AMGN best over 2 years (+43.7%, Sharpe 0.81). Historical/in-sample — walk-forward all 19 →

#StrategyReturnSharpeBeats B&H
1Connors RSI(2)+43.7%0.81
2Donchian Breakout+34.4%0.69
3Stochastic Oscillator+25.1%0.56

Price — 1 year

daily close
$393.10$271.18$385.16 (+29.7% 1Y)

Insider activity

0 open-market buys

Officers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.

DateActionInsiderSharesValue
2026-05-04SELLGrygiel Nancy A1,237$400K
2026-02-26SELLSantos Esteban54,792$20.8M
2026-02-19SELLBusch Matthew C.1,000$376K
2025-11-20SELLGrygiel Nancy A3,139$1.1M
2025-11-12SELLGordon Murdo6,879$2.3M
2025-11-12SELLKhosla Rachna890$299K
2025-08-20SELLGrygiel Nancy A1,267$376K
2025-06-05SELLKhosla Rachna1,500$435K
2025-05-02SELLBusch Matthew C.1,000$280K
2025-02-21SELLReese David M.33,936$10.2M
2025-02-19SELLSantos Esteban8,711$2.6M
2025-02-19SELLMiller Derek2,024$594K

Analyst ratings

live · 5 changes
DateActionAnalystRating Change
2026-04-21InitiatedCanaccord GenuityHold
2026-03-10InitiatedJefferiesHold
2026-02-20InitiatedBarclaysEqual-Weight
2026-02-12DowngradeFreedom BrokerBuy → Hold
2026-01-20DowngradeBernsteinOutperform → Market Perform

Catalyst timeline

16 hub signals
DateSourceEventEntityValue
2026-08-01Earnings (SEC EDGAR)Earnings (est.)AMGN next report ~2026-10-30 (estimated)
2026-07-31SEC EDGAR Filings8-K EventAMGEN INCsource ↗
2026-07-01FDA Approvals & RecallsFDA RecallClass II: Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, — Amgen, Inc.Class IIsource ↗
2026-07-01FDA Approvals & RecallsFDA RecallClass II: Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, — Amgen, Inc.Class IIsource ↗
2026-07-01FDA Approvals & RecallsFDA RecallClass II: Sensipar (cinacalcet) Tablets, 30mg, 30-count bottles, — Amgen, Inc.Class IIsource ↗
2026-07-01FDA Approvals & RecallsFDA RecallClass II: Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 — Amgen, Inc.Class IIsource ↗
2026-07-01FDA Approvals & RecallsFDA RecallClass II: Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, — Amgen, Inc.Class IIsource ↗
2026-06-05U.S. House — Congressional TradesCongress BUYHon. David J. Taylor$1,001 - $15,000source ↗
2026-05-01Earnings (SEC EDGAR)EarningsAMGN FY2026Q1 results8.6Bsource ↗
2026-05-01Earnings (SEC EDGAR)EarningsAMGN FY2026Q1 results8.1Bsource ↗
2026-04-30Earnings (SEC EDGAR)Earnings 8-KAMGN earnings announcement (8-K item 2.02)source ↗
2026-04-17U.S. House — Congressional TradesCongress SELLHon. Maria Elvira Salazar$15,001 - $50,000source ↗
2026-03-27U.S. Senate — Congressional TradesCongress SELLArmstrong, Alan (Senator)$15,001 - $50,000source ↗
2026-03-24U.S. House — Congressional TradesCongress BUYHon. Maria Elvira Salazar$15,001 - $50,000source ↗
2025-11-05Earnings (SEC EDGAR)EarningsAMGN FY2025Q3 results9.6Bsource ↗
2025-08-06Earnings (SEC EDGAR)EarningsAMGN FY2025Q2 results9.2Bsource ↗
Alt-Data Signal Hub · collected signals updated 2026-08-01 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice

All pages

Catalyst EdgeCongressNewsEarningsSEC FilingsHedge FundsLockupsPositioningMarket cycleBacktestOptionsSourcesGlossaryAbout & API